“The opportunity [in India] is large but we don’t want to be limited to being a healthcare player confined to a market”. “Compare a US$500 billion Asian healthcare market with a US$50 billion Indian market. I clearly see a lot more opportunity and a lot more growth happening in international markets.”
The latest figures show that the medical apparatus manufacturing has been shifting to China, China is expected to be the world manufacture of medical apparatus. It matches the reforming point of Chinese industry, which is developing from labor demanding manufacturing to technology and innovation-oriented areas. The figures in analysis of Chinese medical product industry show that the export of Chinese medical products succeeded in trade surplus from the year 2005, which contributes tremendously to the overall Chinese export revenue.
The total health care expenditure of Hong Kong has been gradually increasing. According to Hong Kong’s Domestic Health Accounts (2013), between 1990/91 and 2010/11, annual health care expenditure increased three times to nearly HK$94 billion. From 1989/90 to2010/11, the total health expenditure grows at an average annual rate of 5.9% which rise more quickly than that of GPD (Hong Kong’s Domestic Health Accounts, 2013). Among the public sector and private sector, the increased in total health expenditure from 1989/90 to 2010/2011 was largely driven by the public health expenditure (Hong Kong’s Domestic Health Accounts, 2013). Advancing technology, medical supplies, medical equipment and increasing demand are the main factors of rising health care cost. (Gauld & Gould, 2002)(Roberts, 2006). Roberts (2006) suggests that the new technology including new medication such as organ transplant is the strongest driver of rising health cost. The situation of increased health care demand would be discussed fellow.
Johnson & Johnson (J&J) is an American powerhouse in the healthcare industry. It is number 46 on Forbes list of the World’s Biggest Public Companies (DeCarlo, 2013). It has sixty international locations. J&J has been involved in health related products since 1886. The management structure is decentralized allowing for strategic operations depending on need and location. There are four central business divisions, consumer, pharmaceutical and medical devices and diagnostics. J&J has a significant presence in China and has targeted dominant health concerns, which includes the health issues of their aging population. J&J are not the only global company positioned to address China health care needs. Emeritus and Merrill Gardens are two Seattle, Washington companies whose focus is on senior care. These two companies met in Hong Kong with a group of global investors to discuss the development of the Western for...
This industry is one of the largest growing industries. As consumers are taking more control over their health, using more natural remedies vs. chemical laden drugs, and genetically modified foods.
Pharmaceuticals products sales in Saudi Arabia are expected to surpass US$ 7 Billion by 2018 as compare to US$ 4 Billion 2012. Saudi Arabia is expected to emerge as one of the fastest growing markets in future. The country is one of the most developed and technologically advanced medical sectors in the GCC Region with modern equipment and amenities (Dallas, 2013).
Stanford Medical Center has the opportunity to develop a co-branding arrangement with the government of Saigon, but prior to making a decision – they must consider the risks and benefits. The health care market is continuously evolving; in which America is well-known for its advancements in technology and medical interventions. The co-branding strategy has been successfully implemented by the Mayo Clinic, the Cleveland Clinic, and John Hopkins with other countries across the globe. Therefore, the benefits of this proposal clearly offset the risks involved in working with the Vietnam
At the first glance, from a broad point of view, currently Vietnam pharmaceutical industry possesses around 170 manufacturing companies (not to mention of thousands of business companies). Is it a positive sign that the pharmacy sector is developing ?